Fresenius Medical Care to Close 100 U.S. Clinics as Q1 Revenue Drops 6%
Fresenius Medical Care will close up to 100 U.S. clinics under its FME25+ plan and posted Q1 revenue of $5.40 billion, down 6% year-over-year but up 4% organically. EPS of $0.53 missed the $0.59 estimate, cutting net income 22%, while operating income rose 10% and debt-to-equity remained 0.76.
1. Strategic Transformation
Fresenius Medical Care launched its FME25+ program to enhance profitability, including plans to close up to 100 U.S. clinics as part of a network restructuring.
2. Quarterly Revenue Performance
The company reported Q1 revenue of $5.40 billion, missing consensus by $10 million and marking a 6% year-over-year decline due to currency headwinds and divestitures, offset by 4% organic growth.
3. Profitability and Financial Health
EPS fell to $0.53 versus $0.59 expected, driving a 22% net income drop, while operating income rose 10% for a 10.10% margin and the debt-to-equity ratio remained at 0.76.